Canopy Growth Corporation

NASDAQ:CGC

2.22 (USD) • At close January 14, 2025
Bedrijfsnaam Canopy Growth Corporation
Symbool CGC
Munteenheid USD
Prijs 2.22
Beurswaarde 277,357,656
Dividendpercentage 0%
52-weken bereik 2.19 - 14.92
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. David Eric Klein
Website https://www.canopygrowth.com

An error occurred while fetching data.

Over Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower,

Vergelijkbare Aandelen

Amicus Therapeutics, Inc. logo

Amicus Therapeutics, Inc.

FOLD

9.21 USD

Fate Therapeutics, Inc. logo

Fate Therapeutics, Inc.

FATE

1.255 USD

AbCellera Biologics Inc. logo

AbCellera Biologics Inc.

ABCL

2.77 USD

Corcept Therapeutics Incorporated logo

Corcept Therapeutics Incorporated

CORT

51.66 USD

Allscripts Healthcare Solutions, Inc. logo

Allscripts Healthcare Solutions, Inc.

MDRX

9.25 USD

Alignment Healthcare, Inc. logo

Alignment Healthcare, Inc.

ALHC

13.51 USD

Arvinas, Inc. logo

Arvinas, Inc.

ARVN

17.22 USD

Tilray Brands, Inc. logo

Tilray Brands, Inc.

TLRY

1.18 USD

PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc.

PTCT

41.81 USD

Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM

23.3 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)